文献速递颅颌面外科

PLANA与NAM术前唇鼻牙槽突矫治的早期对比分析

An Early Comparative Analysis of Presurgical Lip, Alveolus, and Nose Approximation and Nasoalveolar Molding.
PubMed 文献 · Plast Reconstr Surg · 2025-08-11

本研究回顾性比较PLANA与NAM两种术前矫治技术在非综合征性唇腭裂患者中的效果,纳入50例(NAM 28例、PLANA 22例),并分析其中25例单侧完全性唇腭裂患者的鼻唇人体测量学比例变化。结果显示PLANA可显著降低就诊次数和短暂可逆性副作用,在鼻小柱长度比例改善上优于NAM,而NAM在鼻孔高度比例改善上更优;两组在鼻孔宽度、鼻翼基底宽度比例及鼻小柱偏斜角上无显著差异。

要点

  • PLANA组总就诊次数较NAM组减少61.2%(5.2次 vs 13.4次,P<0.001)。
  • PLANA组短暂可逆性副作用减少72.19%(18.18% vs 65.38%,P<0.001)。
  • PLANA在鼻小柱长度比例改善上优于NAM(0.53 vs 0.37,P=0.026),NAM在鼻孔高度比例改善上更优(0.29 vs 0.39,P=0.04)。

核心结论

  • PLANA可显著降低唇腭裂患者的治疗负担,并可能提供与NAM相当的鼻唇结局。

研究设计与样本

  • 回顾性研究,纳入50例非综合征性单侧或双侧唇腭裂患者,NAM组28例(含2例中止治疗),PLANA组22例;其中25例单侧完全性唇腭裂患者(PLANA 12例,NAM 13例)进一步分析鼻唇人体测量学比例变化。

主要发现

  • PLANA组总就诊次数较NAM组减少61.2%(5.2次 vs 13.4次,P<0.001)。
  • PLANA组短暂可逆性副作用(口腔、鼻腔及面颊刺激)减少72.19%(18.18% [n=4] vs 65.38% [n=17],P<0.001)。
  • PLANA组鼻小柱长度比例改善显著优于NAM组(0.53 vs 0.37,P=0.026)。
  • NAM组鼻孔高度比例增加显著大于PLANA组(0.29 vs 0.39,P=0.04)。
  • 两组在鼻孔宽度比例、鼻翼基底宽度比例及鼻小柱偏斜角上无显著差异。

临床怎么用

  • 对于希望减少就诊次数和副作用负担的唇腭裂患者,PLANA可作为NAM的替代术前矫治选择。
  • 选择矫治方案时需权衡鼻小柱长度与鼻孔高度改善的侧重,PLANA更利于鼻小柱长度,NAM更利于鼻孔高度。

局限性

  • 回顾性研究设计,样本量有限(总样本50例,影像分析亚组25例)。
  • 仅评估短期结局,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluates the presurgical lip, alveolus, and nose approximation (PLANA) technique as a novel alternative to nasoalveolar molding (NAM). The study hypothesizes that PLANA can achieve comparable nasolabial outcomes to NAM while addressing its limitations, particularly by reducing the burden of care. METHODS: A retrospective review was conducted on 50 patients with nonsyndromic unilateral or bilateral cleft lip and palate (CLP) treated with either NAM ( n = 28, including 2 treatment discontinuations) or PLANA ( n = 22). The overall physical burden of care was assessed in the full cohort. A subset of 25 patients with complete unilateral cleft lip and palate (PLANA, n = 12; NAM, n = 13) was further analyzed to assess changes in nasolabial anthropometric ratios between the cleft and noncleft side using standardized two-dimensional photographs taken before and after treatment. RESULTS: The physical burden of care was significantly lower in the PLANA group, with 61.2% fewer total office visits (5.2 versus 13.4; P < 0.001). The PLANA group also showed a 72.19% reduction in transient reversible side effects, such as oral, nasal, and cheek irritations (18.18% [ n = 4] versus 65.38% [ n = 17]; P < 0.001). PLANA achieved a significantly greater improvement in the columellar length ratio (0.53 versus 0.37; P = 0.026), whereas NAM demonstrated a greater increase in the nostril height ratio (0.29 versus 0.39; P = 0.04). No significant differences were observed in nostril width and alar base width ratios, or columellar deviation angle between the groups. CONCLUSION: These findings suggest that PLANA significantly reduces the burden of care for patients with cleft lip and palate and may offer comparable nasolabial outcomes to NAM.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Multani N, Plana NM, Staffenberg DA, et al. An Early Comparative Analysis of Presurgical Lip, Alveolus, and Nose Approximation and Nasoalveolar Molding. Plast Reconstr Surg. 2025. PMID: 40794405. doi:10.1097/PRS.0000000000012359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。